Community helpers may boost kidney transplant access

NCT ID NCT06655857

Recruiting now Knowledge-focused Sponsor: Icahn School of Medicine at Mount Sinai Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether community health workers and special training for doctors can help more kidney patients get on the transplant waitlist. Five patients will be assigned to either usual care or extra support from a community health worker who addresses social needs like housing or food. The goal is to see if this approach speeds up the waitlisting process.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Community health worker assistance and provider education
What this could lead to: If successful, this could show a way to help more kidney patients get on the transplant waitlist by addressing social needs and reducing bias.
What could go wrong: This is a very small pilot study with only 5 participants, so results may not apply to larger groups. It tests a process, not a treatment, so impact is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KIDNEY TRANSPLANT WAITLISTING

Contacts and locations

Locations

Montefiore Einstein
NOT_YET_RECRUITING

The Bronx, New York, 10467, United States
Mount Sinai Hospital
RECRUITING

New York, New York, 10029, United States
NYU Langone Health
NOT_YET_RECRUITING

New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.